Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transforming growth factor-beta-induced protein ig-h3 (TGFBI/βig-H3) is a secreted extracellular matrix (ECM) protein that plays key roles in cell adhesion, migration, proliferation, and differentiation. Mutations in the TGFBI gene are associated with several corneal dystrophies and may contribute to other pathologies like cancer and fibrosis. It interacts with various ECM components and integrins, modulating cellular responses.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transforming growth factor-beta-induced protein ig-h3 (TGFBI).